Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Jonathan Rees will take up the leadership role on 1 April.

Horizontal portrait of Jonathan Rees

Professor Jonathan Rees is the Director of the Botnar Institute for Musculoskeletal Sciences at the University of Oxford and is Honorary Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre.  



I am honoured to be taking over the Headship of NDORMS from Professor Andy Carr. Over the last 20 years Andy has steered the department to its position as an internationally renowned musculoskeletal research and teaching department. I look forward to working closely with all our staff and students to deliver world class research and new discoveries to improve the lives of people suffering with musculoskeletal pain and disability.
Professor Jonathan Rees


Professor Andrew Carr will step down at the end of March as NDORMS Head of Department after 21 years. During that time he has realised a vision, alongside the comprehensive rebuild of the Nuffield Orthopaedic Centre Hospital (NOC), to construct the three wings of Botnar Research Institute on the hospital site, and the move of the Kennedy Institute for Rheumatology to Oxford, bringing world leading research hand-in-hand with NHS patient care.

Professor Gavin Screaton, Head of the Medical Sciences Division commented: “I would like to take this opportunity to thank Andy for his 21 years of service to the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, and welcome Professor Jonathan Rees as the new Head of Department.  

Under Andy’s tenure, NDORMS has grown significantly from 20 to over 500 research staff and students. His research in defining the use of the Oxford Knee as a partial knee replacement and the development of Oxford Score to assess patients’ views of surgical outcomes has been hugely impactful to millions of patients across the world. He has also been instrumental in pioneering the use of randomised clinical trials of surgery to improve evidence for commonly performed operations. I wish Andy continued success in the new phase of his career. 

Jonathan takes over leadership of the Department at an exciting time, with the recent opening of the Marcela Botnar wing. The new wing will house a cohort of bioengineers, all researching ways to improve the treatment of arthritis, osteoporosis and other bone and joint diseases. I wish Jonathan every success in these new endeavours and look forward to hearing more good news from the Department.”

Professor Andrew Carr, current Head of Department said: “It is wonderful to hear that Professor Jonny Rees will be taking on the headship of NDORMS in April this year. I have no doubt that he will provide huge energy and inspirational leadership in the role and I wish him every success.” 

Prof Rees profile

Graduating from St Mary's Hospital Medical School, London, Prof Rees then trained in orthopaedic surgery in Oxford. He was appointed Clinical Lecturer to NDORMS in 2004 and then University Lecturer in 2005. He continued as a consultant shoulder and elbow surgeon, while teaching, training and running a musculoskeletal research programme before becoming Professor of Orthopaedic Surgery and Musculoskeletal Science in 2014. He has a number of national roles including President of the British Elbow and Shoulder Society, and is an NIHR Senior Investigator. Besides his University and national work, he continues to work as a Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre


Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.